Identifying risks of heart failure and cognitive decline in people with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify patients with type 2 diabetes who are at risk of developing heart failure and cognitive decline. By focusing on early detection, the study seeks to develop personalized preventive strategies for these conditions. Participants will be adults with type 2 diabetes who do not have heart failure at stage B or dementia. The study will gather data to better understand the relationship between diabetes and these serious health issues.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults
* Persons able to understand and object to the information provided.
* Type 2 diabetic patient free of heart failure ≥stade B
* Patient affiliated with a social security scheme.
* Patient agreeing to sign the informed consent form

Exclusion Criteria:

* Patient with dementia
* Patient with at least one of the criteria for heart failure ≥stade B

Where it's running

• Hopital Roger Salengro, CHU Lille
  Lille, France Recruiting

Study contacts

• Principal investigator: Charlotte Cordonnier, MD,PhD — University Hospital, Lille
• Study coordinator: Charlotte Cordonnier, MD,PhD
• Email: precidiab_heart_brain@chru-lille.fr
• Phone: 0320445962

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive screening and multidomain care to slow memory and thinking decline in older adults with type 2 diabetes

  This study will test whether regular cognitive screening plus a two-year program of medication optimization, adjusted HbA1c targets, vascular risk management, lifestyle changes, and social support can slow cognitive decline in people aged 65 and older with type 2 diabetes.

  Recruiting at 3 sites Steno Diabetes Center Copenhagen · Copenhagen and 2 other locations · NCT07250789

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Exploring heart failure and diabetes interactions

  This study looks at how heart failure and diabetes affect the body differently by testing 600 people with various combinations of these conditions.

  Recruiting University of Leeds · Leeds, West Yorkshire · NCT06774014

• Comparing two diabetes medications, empagliflozin and dapagliflozin

  This study is testing which diabetes medication, empagliflozin or dapagliflozin, works better for people with type 2 diabetes, chronic kidney disease, and heart failure.

  Recruiting at 12 sites Phase 4 Herlev and Gentofte Hospital · Copenhagen and 11 other locations · NCT06642272

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Identifying biomarkers in patients with Type 2 Diabetes and heart failure

  This study is trying to find specific markers in the blood of people with Type 2 Diabetes and heart failure to see if they can help predict who will benefit from a heart treatment.

  Recruiting RWTH Aachen University · Aachen, North Rhine-Westphalia · NCT03323216

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.